Evidence map›Paper›PMID 15039303›Full record

ReviewInfection and immunity2004

Chlamydial persistence: beyond the biphasic paradigm.

Richard J Hogan, Sarah A Mathews, Sanghamitra Mukhopadhyay, James T Summersgill, Peter Timms

Abstract readReview
In one paragraph

Review in Infection and immunity, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 167 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
167citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

167 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Trial
  5. Article
  6. Pyocyanin reversibly inhibitsFrontiers in pharmacology · 2026
    Article
  7. Article
  8. Journal of bacteriology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Association ofFrontiers in cellular and infection microbiology · 2023
    Article
  15. Therapeutic Options forAntibiotics (Basel, Switzerland) · 2022
    Review
  16. Article
  17. Prevalence ofInfectious disease reports · 2022
    Article
  18. Diagnostics (Basel, Switzerland) · 2022
    Review
  19. New insights intoFrontiers in cellular and infection microbiology · 2022
    Review
  20. Article

107 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Richard J HoganInfectious Diseases Program and Cooperative Research Centre for Diagnostics, School of Life Sciences, Queensland University of Technology, Brisbane, Australia.
Sarah A Mathews
Sanghamitra Mukhopadhyay
James T Summersgill
Peter Timms

Funding

Proteomic Analysis of Persistent Chlamydia pneumoniaeR01HL068874 · NHLBI · UNIVERSITY OF LOUISVILLE · PI SUMMERSGILL, JAMES T. · 2002 to 2004
$752k
Gene Expression of Persistent Chlamydia pneumoniaeR21AI051255 · NIAID · UNIVERSITY OF LOUISVILLE · PI SUMMERSGILL, JAMES T. · 2002 to 2003
$325k
NHLBI NIH HHS HL68874NHLBI NIH HHS R01 HL068874NIAID NIH HHS AI51255NIAID NIH HHS R21 AI051255
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression Regulation, BacterialBacterial ProteinsChlamydiaChlamydia InfectionsChlamydia trachomatisChlamydophila pneumoniaeChronic DiseaseHumansBacterial Proteins

Identifiers

PMID15039303
PMCPMC375192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.